Skip to main content
. 2020 Jan 30;9(3):e014581. doi: 10.1161/JAHA.119.014581

Figure 3.

Figure 3

Difference of cardiovascular outcomes according to lipoprotein(a) levels. A, The cumulative event‐free survival analysis according to the median of lipoprotein(a); (B) the cumulative event‐free survival analysis according to lipoprotein(a) levels of 15 and 30 mg/dL; (C) the cardiovascular events incidence according to the median of lipoprotein(a); and (D) the cardiovascular events incidence according to lipoprotein(a) levels of 15 and 30 mg/dL. CVD indicates cardiovascular disease; MI, myocardial infarction. *P<0.05 compared with the low lipoprotein(a) group.